MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma
- PMID: 20231369
- DOI: 10.1530/EJE-09-1100
MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma
Abstract
Objective: The purpose of this study was to evaluate whether MIB-1 labeling index (LI) could be used to predict growth velocity of residual pituitary adenomas after surgery.
Materials and methods: One hundred and sixty pituitary adenomas which had not received other treatment modality except for surgery were collected. Each of them had at least two post-operative magnetic resonance imaging (MRI) studies with an interval of at least 1 month apart. Tumor volume doubling time (TVDT) was calculated for those in which volume increased.
Results: Post-operative tumor progression was noted in 54 (33.8%) cases, of which 39 (72.2%) cases were non-functioning adenomas. The MIB-1 LIs of the functioning and non-functioning adenomas were not significantly different. The median TVDT of these 54 cases was 34.6 months. The mean and median MIB-1 LI were 2.7 and 1.1 respectively (range 0.4-20.6). The MIB-1 LI was significantly correlated with log(2)(TVDT) (r=-0.363, P=0.007); when LI was <0.8, the TVDT of 90.5% cases was >or= 2 years.
Conclusions: Only one-third of the pituitary adenomas progressed after surgery, and their MIB-1 LIs were generally low. The MIB-1 LI was significantly correlated with the MRI detected TVDT of post-operative residual pituitary adenomas.
Similar articles
-
Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.J Neurosurg. 2003 Feb;98(2):359-65. doi: 10.3171/jns.2003.98.2.0359. J Neurosurg. 2003. PMID: 12593623
-
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):80-5. doi: 10.1055/s-2007-991131. Epub 2007 Dec 10. Exp Clin Endocrinol Diabetes. 2008. PMID: 18072009
-
Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.J Neurosurg. 2009 Sep;111(3):563-71. doi: 10.3171/2008.4.17517. J Neurosurg. 2009. PMID: 18991501
-
Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.Neurol Res. 2010 Dec;32(10):1060-71. doi: 10.1179/016164110X12670144737855. Epub 2010 May 18. Neurol Res. 2010. PMID: 20483025 Review.
-
Post-operative imaging assessment of non-functioning pituitary adenomas.Acta Neurochir (Wien). 2018 May;160(5):1029-1039. doi: 10.1007/s00701-018-3491-2. Epub 2018 Feb 16. Acta Neurochir (Wien). 2018. PMID: 29453734 Review.
Cited by
-
Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.Endocrine. 2019 Nov;66(2):310-318. doi: 10.1007/s12020-019-02029-1. Epub 2019 Jul 31. Endocrine. 2019. PMID: 31368083
-
MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas.Pituitary. 2017 Dec;20(6):643-653. doi: 10.1007/s11102-017-0829-3. Pituitary. 2017. PMID: 28900805 Free PMC article.
-
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.Acta Neuropathol Commun. 2015 Aug 19;3:50. doi: 10.1186/s40478-015-0229-8. Acta Neuropathol Commun. 2015. PMID: 26285571 Free PMC article.
-
Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study.Medicine (Baltimore). 2020 Oct 9;99(41):e22673. doi: 10.1097/MD.0000000000022673. Medicine (Baltimore). 2020. PMID: 33031334 Free PMC article.
-
Predictive value of cyst/tumor volume ratio of pituitary adenoma for tumor cell proliferation.BMC Med Imaging. 2024 Mar 21;24(1):69. doi: 10.1186/s12880-024-01246-z. BMC Med Imaging. 2024. PMID: 38515047 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical